yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q36196484-1869C079-E300-4CEB-A4FD-ADB0976E9DF4
Q36196484-1869C079-E300-4CEB-A4FD-ADB0976E9DF4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36196484-1869C079-E300-4CEB-A4FD-ADB0976E9DF4
Novel agents in development for the treatment of melanoma.
P2860
Q36196484-1869C079-E300-4CEB-A4FD-ADB0976E9DF4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36196484-1869C079-E300-4CEB-A4FD-ADB0976E9DF4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5eb102837f2ad2cb8191205ef3e4c70963afefe6
P2860
Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer